Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Other disposition Director disposed of 571,741 shares (other)
  2. 4 Other acquisition Chief Legal Officer acquired 55,668 shares (other)
  3. 4 Other acquisition Chief Financial Officer acquired 4,790 shares (other)
  4. 4 Other acquisition President and CEO acquired 86,476 shares (other)
  5. 4 Open-market sale 10% owner sold 525,550 shares at an average $24.19 ($12,713,502)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Other disposition 10% owner disposed of 130,571 shares (other)
  9. 4 Open-market sale Chief Legal Officer sold 3,738 shares at $20.35 ($76,068)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Other disposition 10% owner disposed of 1,014,381 shares (other)
  15. 4 Open-market buy 10% owner bought 39,726 shares at an average $17.15 ($681,470)
  16. 4 Open-market buy 10% owner bought 7,803 shares at an average $19.87 ($155,072)
  17. 4 Open-market buy 10% owner bought 15,637 shares at an average $19.10 ($298,738)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 21 · 414 filings